GSTM1 and mismatch repair cancer syndrome 1: BRAF mutation (p = 0.010; borderline statistical significance considering multiple hypothesis testing) associated with a tendency towards lower Hb levels, while MMR deficiency associated with significantly lower blood Hb (p < 0.001; Table 2).